Similar articles

• Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.

  Timberlake WH. Timberlake WH. Neurology. 1970 Dec;20(12):Suppl:31-5. Neurology. 1970. PMID: 4921586 Clinical Trial. No abstract available.
• L-dopa and amantadine in the therapy of parkinsonism.

  Weeth JB, Shealy CN, Mercier DA. Weeth JB, et al. Wis Med J. 1969 Nov;68(11):325-8. Wis Med J. 1969. PMID: 4901055 Clinical Trial. No abstract available.
• Metabolism and clinical assessment of L-dopa in parkinsonism.

  Ericsson AD, McCann D, Sharpless N, Reveno W. Ericsson AD, et al. Neurology. 1970 Apr;20(4):402. Neurology. 1970. PMID: 4935027 Clinical Trial. No abstract available.
• L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.

  Goodwin FK, Murphy DL, Brodie HK, Bunney WE Jr. Goodwin FK, et al. Biol Psychiatry. 1970 Oct;2(4):341-66. Biol Psychiatry. 1970. PMID: 4920729 Review. No abstract available.
• [Treatment of Parkinson's disease with L-dopa].

  Guglielmi L, Vecchi L. Guglielmi L, et al. Clin Ter. 1970 May 15;53(3):259-69. Clin Ter. 1970. PMID: 4917328 Review. Italian. No abstract available.